Covaxin Phase 3 Trial

Covaxin phase-3 trial will begin as second trial has successful results | India | Corona Vaccine

WION

‘Covaxin has 81% efficacy’: Bharat Biotech phase 3 trial results

Hindustan Times

Covaxin 77.8% Effective In Phase 3 Trial Data: Sources

NDTV

Covid-19 Vaccine: Covaxin Phase 3 Trial Data Shared With Expert Panel Which Meets Today

NDTV

Phase III Trials Of Bharat Biotech's Covaxin | CNBC-TV18

Bharat Biotech's Covaxin Shows 77.8% Efficacy Rate In Phase 3 Trial

Covaxin shows 77.8% efficacy in phase 3 trial data: All you need to know | Covid

Hindustan Times

Bharat Biotech Enrols Over 25,000 Volunteers For Covaxin Phase 3 Trial

NDTV

Covaxin Shows 77.8% Efficacy In Phase 3 Trial

Bharat Biotech Covaxin phase III trial is approved by Subject Expert Committee with 77.8% efficacy

Covaxin Shows 77% Efficacy In Phase 3 Trials, Bharat Biotech Informs Govt Panel, Data Under Review

Covaxin Interim Results 'Encouraging', Phase 3 Trials To Continue: AIIMS Chief

NDTV

Covid update: Covaxin phase 3 trial; China locks down Hebei; UK vaccine supply

Hindustan Times

Bharat biotech submits phase 3 trial data, expert panel meet today| Covaxin | Oneindia News

‘Covaxin phase-3 trial probably largest clinical trial in India’: Principal Investigator

Covid-19 Vaccine: Bharat Biotech Releases Covaxin's Phase 3 Trial Data, Claims 77.8% Efficacy

NDTV

Bharat Biotech Concludes Phase 3 trial Of Covaxin Records 77.8% Efficacy Rate

81% Interim Clinical Efficacy For Bharat Biotech’s Made-In-India COVID-19 Vaccine, Covaxin

Covaxin: Bharat Biotech Granted Permission To Start Phase-3 Trials For Covid-19 Vaccine

Covid-19 News: 70-80% Decline In Participants For Phase3 Trial Of Bharat Biotech's Covaxin

NDTV